Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 4, 2000, Pages 344-351

  Mouly, Stephane ^a,c   Aymard, Guy ^b   Diquet, Bertrand ^b   Caulin, Charles ^a   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

HIV; Intestinal absorption; Oral ganciclovir; Pharmacokinetics

Indexed keywords

ALBUMIN; CD4 ANTIGEN; FECES LIPID; GANCICLOVIR; NITROGEN; TRANSFERRIN; XYLOSE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHRONIC DIARRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALABSORPTION; MALE; NITROGEN URINE LEVEL; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; VIRUS LOAD; WASTING SYNDROME; WEIGHT REDUCTION; XYLOSE TEST;

EID: 0034253042     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200008010-00008     Document Type: Article

References (38)

1. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant
2. Effect of food on the relative bioavailability of oral ganciclovir
3. Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group
4. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome
5. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS)
6. Gastric acid secretion in HIV-1 infection
7. Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea
8. Intestinal absorptive capacity, intestinal permeability, and jejunal histology in HIV and their relation to diarrhea
9. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with celiac disease
10. Histopathologic findings of duodenal biopsy specimen in HIV-infected patients with and without diarrhea and malabsorption
11. Gastrointestinal function and structure in HIV-positive patients
12. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): Evidence for HIV-induced enteropathy
13. Clinical pharmacokinetics of zidovudine: Inter and intraindividual variability and relationship to long term efficacy and toxicity
14. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection
15. Population pharmacokinetics of rifabutin in human immunodeficiency virus-infected patients
16. Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease
17. Problems in pharmacokinetic investigations in patients with HIV infection
18. Intestinal absorption and permeability in human immunodeficiency virus-infected patients
19. Pharmacokinetics of fluconazole in people with HIV infection: A population analysis
20. Prediction of creatinine clearance from serum creatinine
21. 1993 Revised classification system for HIV infection and expanded surveillance case definition for ADS among adolescents and adults
22. Gas chromatography applied to the lactulose-mannitol intestinal permeability test
23. Premarketing observational studies of population pharmacokinetics of new drugs
24. HPLC determination of serum ganciclovir using ultrafiltration, ultraviolet and fluorescence detection
25. Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients
26. Population pharmacokinetics of high dose thiopental in patients with cerebral injuries
27. Investigation of seemingly pathogen-negative diarrhoea in patients infected with HIV1
28. Investigation of chronic diarrhea in acquired immunodeficiency syndrome. A prospective study of 155 patients
29. Ultrastructure of the jejunal mucosa in human immunodeficiency vires infection
30. Cytokine gene expression in HIV-infected intestinal mucosa
31. Increased number of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patients
32. Steady-state relative bioavailability of three oral ganciclovir dosage regimens delivering 6,000 mg/day in patients with human immunodeficiency virus
33. The impact of HIV infection on lactose absorptive capacity
34. Jejunal mucosal architecture and fat malabsorption in male homosexuals infected with human immunodeficiency virus
35. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
36. The barrier function of CYP3A4 and P-glycoprotein in the small bowel